SVB Leerink’s full suite

Company, banker perspectives on SVB Leerink merger

The planned $280 million acquisition of Leerink Partners by SVB Financial Group (NASDAQ:SIVB) is expected to provide biotechs with a new one stop shop for financial services.

SVB, a commercial lender with a dedicated healthcare team, provided debt financing for nearly two-thirds of VC-backed

Read the full 449 word article

User Sign In